Vecuronium Bromide

Especificaciones

50700-72-6Número CAS

256-723-9Número CE

[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate bromideNombre IUPAC

C34H57BrN2O4Fórmula química

637.7 g/molPeso molecular

VECURONIUM BROMIDE; 50700-72-6; Norcuron; Bromuro de vecuronio; Bromure de vecuronium; Vecuronii bromidum; ORG NC 45; ORG-NC 45; DTXSID1023736; NC-45; 7E4PHP5N1D; Musculax; NSC-759184; CHEBI:9940; DTXCID003736; Bromide, Vecuronium; Piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl)-1-methyl-, bromide; Vecuronium Hydrobromide; ORG-NC45; vAcuronium; Vercuronium; vecuronio bromuro; NC 45; Citrate, Vecuronium; Maleate, Vecuronium; Phosphate, Vecuronium; Hydrobromide, Vecuronium; RefChem:56989; Hydrochloride, Vecuronium; ORGNC45; ORG NC45; ORGNC 45; NC45; M03AC03; 256-723-9; Vecuronium (bromide); MFCD00867762; 1-((2S,3S,5S,10S,13S,16S,17R)-3,17-Diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium bromide; 1-(3alpha,17beta-Dihydroxy-2beta-piperidino-5alpha-androstan-16beta,5alpha-yl)-1-methylpiperidinium bromide, diacetate; [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide; (+)-1-(3,17-diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium bromide; [(2S,3S,10S,13S,16S,17R)-17-Acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide; 1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3,17-diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium bromide; C34H57BrN2O4; CAS-50700-72-6; Vecuronii bromidum [INN-Latin]; NCGC00167467-01; Bromure de vecuronium [INN-French]; Bromuro de vecuronio [INN-Spanish]; EINECS 256-723-9; UNII-7E4PHP5N1D; vecronium bromide; Norcuron (TN); Vecuronium Bromide?; Vecuronium bromide CRS; Vecuronium bromide [USAN:USP:INN:BAN:JAN]; 5alpha-Androstan-3alpha,17beta-diol, 16beta-pipecolinio-2beta-piperidino-,bromide,diacetate; SCHEMBL22250; MLS001424317; HY-B0118AR; VECURONIUM BROMIDE [MI]; CHEMBL1200629; VECURONIUM BROMIDE [INN]; VECURONIUM BROMIDE [JAN]; HY-B0118A; Vecuronium (bromide) (Standard); VECURONIUM BROMIDE [USAN]; VEPSYABRBFXYIB-PWXDFCLTSA-M; GLXC-03043; HMS2052I21; HMS3715L15; HMS3884C15; Pancuronium Bromide EP Impurity D; VECURONIUM BROMIDE [VANDF]; VECURONIUM BROMIDE [MART.]; Vecuronium bromide (JAN/USP/INN); VECURONIUM BROMIDE [USP-RS]; VECURONIUM BROMIDE [WHO-DD]; Tox21_112471; EBC-11164; Vecuronium for system suitability CRS; AKOS005145904; AKOS007930694; Tox21_112471_1; AC-2000; CCG-101147; CS-1881; FV61481; NC00397; NSC 759184; VECURONIUM BROMIDE [EP IMPURITY]; VECURONIUM BROMIDE [ORANGE BOOK]; NCGC00167467-03; VECURONIUM BROMIDE [EP MONOGRAPH]; DS-12625; Piperidinium, 1-(3-alpha,17-beta-diacetoxy-2-beta-piperidino-5-alpha-androstan-16-beta-yl)-1-methyl-, bromide; SMR000471625; VECURONIUM BROMIDE [USP MONOGRAPH]; NS00078739; V0120; V1810; D00767; EN300-122368; F863083; Pancuronium bromide impurity, vecuronium bromide -; SR-01000763634; PANCURONIUM BROMIDE IMPURITY D [EP IMPURITY]; SR-01000763634-3; Q27108523; Vecuronium Bromide; Pancuronium Bromide EP Impurity D; Z1541759894; Vecuronium Bromide Working Standard (Secondary Reference Standard); Vecuronium bromide, European Pharmacopoeia (EP) Reference Standard; PANCURONIUM BROMIDE IMPURITY, VECURONIUM BROMIDE - [USP IMPURITY]; Vecuronium bromide, United States Pharmacopeia (USP) Reference Standard; 1-(3,17-Diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium bromide; Vecuronium Bromide, Pharmaceutical Secondary Standard; Certified Reference Material; Vecuronium for system suitability, European Pharmacopoeia (EP) Reference Standard; (2beta,3alpha,5alpha,16beta,17beta)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane bromide; [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide; [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-acetyloxy-10,13-dimethyl-16-(1-methyl-3,4,5,6-tetrahydro-2H-pyridin-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate Bromide; 1-((2S,3S,5S,10S,13S,16S,17R)-3,17-Diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-iumbromide; 1-[(1R,2S,3aS,3bR,5aS,7S,8S,9aS,9bS,11aS)-1,7-bis(acetyloxy)-9a,11a-dimethyl-8-(piperidin-1-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-2-yl]-1-methylpiperidin-1-ium bromide; 1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide; 1-[3alpha,17beta-bis(acetoxy)-2beta-(1-piperidinyl)-5alpha-androstan-16beta-yl]-1-methylpiperidinium bromide; 3alpha,17beta-Bis(acetyloxy)-16beta-(1-methylpiperidin-1-ium-1-yl)-2beta-(piperidin-1-yl)-5alpha-androstane bromide; PIPERIDINIUM, 1-((2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-3,17-BIS(ACETYLOXY)-2-(1-PIPERIDINYL)ANDROSTAN-16-YL)-1-METHYL-, BROMIDESinónimos